Toxin-independent virulence of Bacillus anthracis in rabbits

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Levy, Haim ^a   Glinert, Itai ^a   Weiss, Shay ^a   Sittner, Assa ^a   Schlomovitz, Josef ^a   Altboum, Zeev ^a   Kobiler, David ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTEREMIA; BACTERIAL VIRULENCE; CONTROLLED STUDY; FEMALE; GUINEA PIG; HOST CELL; IMMUNOBLOTTING; MICROBIAL ATTENUATION; NONHUMAN; PATHOGENICITY; RABBIT;

ANIMALS; BACILLUS ANTHRACIS; BACTERIAL CAPSULES; FEMALE; MUTATION; RABBITS; SPORES, BACTERIAL; TOXINS, BIOLOGICAL; VIRULENCE;

EID: 84897102945     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084947     Document Type: Article

References (31)

1. Cote CK, Welkos SL, Bozue J (2011) Key aspects of the molecular and cellular basis of inhalational anthrax. Microbes Infect 13: 1146-1155.
2. Fouet A, Mock M (1996) Differential influence of the two Bacillus anthracis plasmids on regulation of virulence gene expression. Infect Immun 64: 4928-4932. (Pubitemid 26403943)
3. Fouet A (2010) AtxA, a Bacillus anthracis global virulence regulator. Res Microbiol 161: 735-742.
4. Uchida I, Hornung JM, Thorne CB, Klimpel KR, Leppla SH (1993) Cloning and characterization of a gene whose product is a trans-activator of anthrax toxin synthesis. J Bacteriol 175: 5329-5338. (Pubitemid 23264426)
5. Koehler TM, Dai Z, Kaufman-Yarbray M (1994) Regulation of the Bacillus anthracis protective antigen gene: CO2 and a trans-acting element activate transcription from one of two promoters. J Bacteriol 176: 586-595. (Pubitemid 24043946)
6. Levy H, Weiss S, Altboum Z, Schlomovitz J, Glinert I, et al. (2012) Differential Contribution of Bacillus anthracis Toxins to Pathogenicity in Two Animal Models. Infect Immun 80: 2623-2631.
7. Levy H, Weiss S, Altboum Z, Schlomovitz J, Rothschild N, et al. (2011) Lethal factor is not required for Bacillus anthracis virulence in guinea pigs and rabbits. Microb Pathog 51: 345-351.
8. Levy H, Weiss S, Altboum Z, Schlomovitz J, Rothschild N, et al. (2012) The effect of deletion of the edema factor on Bacillus anthracis pathogenicity in guinea pigs and rabbits. Microb Pathog 52: 55-60.
9. Lovchik JA, Drysdale M, Koehler TM, Hutt JA, Lyons CR (2012) Expression of either Lethal Toxin or Edema Toxin by Bacillus anthracis Is Sufficient for Virulence in a Rabbit Model of Inhalational Anthrax. Infect Immun 80: 2414-2425.
10. Guichard A, Nizet V, Bier E (2012) New insights into the biological effects of anthrax toxins: linking cellular to organismal responses. Microbes and Infection 14: 22.
11. Welkos S, Little S, Friedlander A, Fritz D, Fellows P (2001) The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology 147: 1677-1685. (Pubitemid 32544833)
12. Froude JW, Stiles B, Pelat T, Thullier P (2011) Antibodies for biodefense. MAbs 3: 517-527.
13. Froude JW 2nd, Thullier P, Pelat T (2011) Antibodies against anthrax: mechanisms of action and clinical applications. Toxins (Basel) 3: 1433-1452.
14. Chen Z, Moayeri M, Purcell R (2011) Monoclonal Antibody Therapies against Anthrax. Toxins (Basel) 3: 1004-1019.
15. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloining a laboratory manual: Cold Spring Harbor Laboratory Press.
16. Kobiler D, Gozes Y, Rosenberg H, Marcus D, Reuveny S, et al. (2002) Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization. Infect Immun 70: 544-560.
17. Levy H, Fisher M, Ariel N, Altboum Z, Kobiler D (2005) Identification of strain specific markers in Bacillus anthracis by random amplification of polymorphic DNA. FEMS Microbiol Lett 244: 199-205. (Pubitemid 40267703)
18. Cohen S, Mendelson I, Altboum Z, Kobiler D, Elhanany E, et al. (2000) Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun 68: 4549-4558. (Pubitemid 30497722)
19. Janes BK, Stibitz S (2006) Routine markerless gene replacement in Bacillus anthracis. Infection and Immunity 74: 1949-1953. (Pubitemid 43346834)
20. Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Hyg 27: 493-497.
21. Weiss S, Kobiler D, Levy H, Pass A, Ophir Y, et al. (2011) Antibiotics cure anthrax in animal models. Antimicrob Agents Chemother 55: 1533-1542.
22. Kobiler D, Weiss S, Levy H, Fisher M, Mechaly A, et al. (2006) Protective antigen as a correlative marker for anthrax in animal models. Infect Immun 74: 5871-5876. (Pubitemid 44484574)
23. Moayeri M, Leppla SH (2009) Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Aspects Med 30: 439-455.
24. Green BD, Battisti L, Koehler TM, Thorne CB, Ivins BE (1985) Demonstration of a capsule plasmid in Bacillus anthracis. Infect Immun 49: 291-297. (Pubitemid 15004855)
25. Chateau A, van Schaik W, Six A, Aucher W, Fouet A (2011) CodY regulation is required for full virulence and heme iron acquisition in Bacillus anthracis. FASEB J 25: 4445-4456.
26. Ariel N, Zvi A, Makarova KS, Chitlaru T, Elhanany E, et al. (2003) Genomebased bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens. Infect Immun 71: 4563-4579. (Pubitemid 36919923)
27. Kern JW, Schneewind O (2008) BslA, a pXO1-encoded adhesin of Bacillus anthracis. Mol Microbiol 68: 504-515. (Pubitemid 351422969)
28. Kern J, Schneewind O (2010) BslA, the S-layer adhesin of B. anthracis, is a virulence factor for anthrax pathogenesis. Mol Microbiol 75: 324-332.
29. Kern J, Ryan C, Faull K, Schneewind O (2010) Bacillus anthracis surface-layer proteins assemble by binding to the secondary cell wall polysaccharide in a manner that requires csaB and tagO. J Mol Biol 401: 757-775.
30. Ebrahimi CM, Kern JW, Sheen TR, Ebrahimi-Fardooee MA, van Sorge NM, et al. (2009) Penetration of the blood-brain barrier by Bacillus anthracis requires the pXO1-encoded BslA protein. J Bacteriol 191: 7165-7173.
31. Yoong P, Schuch R, Nelson D, Fischetti VA (2006) PlyPH, a bacteriolytic enzyme with a broad pH range of activiry and lytic action against Bacillus anthracis. J Bacteriol 188: 4.